Published in Drugs on January 01, 2005
Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005. Ann Rheum Dis (2005) 1.77
Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents. Br J Pharmacol (2007) 1.77
Pattern and predictors of the initiation of biologic agents for the treatment of rheumatoid arthritis in the United States: an analysis using a large observational data bank. Clin Ther (2009) 1.01
Can we derive an 'exchange rate' between descriptive and preference-based outcome measures for stroke? Results from the transfer to utility (TTU) technique. Health Qual Life Outcomes (2009) 0.95
Cost-effectiveness modeling of abatacept versus other biologic agents in DMARDS and anti-TNF inadequate responders for the management of moderate to severe rheumatoid arthritis. Clin Rheumatol (2008) 0.84
TNFalpha blockers do not improve the hearing recovery obtained with glucocorticoid therapy in an autoimmune experimental labyrinthitis. Eur Arch Otorhinolaryngol (2006) 0.82
Introduction to economic modeling for clinical rheumatologists: application to biologic agents in rheumatoid arthritis. Clin Rheumatol (2011) 0.81
Anti-inflammatory and anti-arthritic activities of 3,4-dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-dione (β-lapachone). Inflamm Res (2012) 0.80
Thoughts on health economics in rheumatoid arthritis. Ann Rheum Dis (2007) 0.80
Economic evaluation of anti-TNF agents for patients with rheumatoid arthritis in Greece. Clinicoecon Outcomes Res (2015) 0.78
[Health-economic assessment of combination therapy for rheumatoid arthritis with methotrexat and etanercept based on the TEMPO Study]. Z Rheumatol (2009) 0.77
Do Biologic Therapies for Rheumatoid Arthritis Offset Treatment-Related Resource Utilization and Cost? A Review of the Literature and an Instrumental Variable Analysis. Curr Rheumatol Rep (2017) 0.75
Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet (2010) 12.92
The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health (2009) 9.79
Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med (2009) 5.36
Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health (2011) 5.12
Policy options for alcohol price regulation: the importance of modelling population heterogeneity. Addiction (2009) 4.61
Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. Arch Dermatol (2007) 4.36
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum (2008) 4.20
Estimated effect of alcohol pricing policies on health and health economic outcomes in England: an epidemiological model. Lancet (2010) 3.82
Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med (2013) 3.51
Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis. Ann Intern Med (2009) 3.03
Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health (2013) 2.82
Does antibiotic exposure during infancy lead to development of asthma?: a systematic review and metaanalysis. Chest (2006) 2.37
Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum (2005) 2.20
Long-term (10-year) mortality of younger previously healthy patients with severe sepsis/septic shock is worse than that of patients with nonseptic critical illness and of the general population. Crit Care Med (2014) 2.19
Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure. CMAJ (2003) 2.18
Safety and efficiency of emergency department assessment of chest discomfort. CMAJ (2004) 2.09
A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med (2005) 2.07
Cost-effectiveness of using a molecular diagnostic test to improve preoperative diagnosis of thyroid cancer. Value Health (2012) 2.06
Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis. Arthritis Rheum (2004) 1.87
Measuring health-related quality of life in tuberculosis: a systematic review. Health Qual Life Outcomes (2009) 1.85
Intensive care unit admission has minimal impact on long-term mortality. Crit Care Med (2002) 1.73
Antibiotic use in children is associated with increased risk of asthma. Pediatrics (2009) 1.68
Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea. Arch Intern Med (2006) 1.68
The economic impact of obstructive sleep apnea. Lung (2007) 1.65
Cardiovascular risk factor screening in systemic lupus erythematosus. J Rheumatol (2003) 1.64
Productivity loss due to presenteeism among patients with arthritis: estimates from 4 instruments. J Rheumatol (2010) 1.64
Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? Arthritis Rheum (2008) 1.63
Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study. Addiction (2012) 1.62
Alcohol tax pass-through across the product and price range: do retailers treat cheap alcohol differently? Addiction (2014) 1.62
Adjusting for unrecorded consumption in survey and per capita sales data: quantification of impact on gender- and age-specific alcohol-attributable fractions for oral and pharyngeal cancers in Great Britain. Alcohol Alcohol (2013) 1.59
Effect of sociodemographic factors on surgical consultations and hip or knee replacements among patients with osteoarthritis in British Columbia, Canada. J Rheumatol (2010) 1.57
The relationship between osteoarthritis and cardiovascular disease in a population health survey: a cross-sectional study. BMJ Open (2013) 1.55
Managing arthritis and employment: making arthritis-related work changes as a means of adaptation. Arthritis Rheum (2004) 1.54
Workplace, psychosocial factors, and depressive symptoms among working people with arthritis: a longitudinal study. J Rheumatol (2006) 1.54
Measuring and valuing productivity loss due to poor health: A critical review. Soc Sci Med (2010) 1.52
Evaluating health-related quality-of-life studies in paediatric populations: some conceptual, methodological and developmental considerations and recent applications. Pharmacoeconomics (2005) 1.50
Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability. Am J Hum Genet (2010) 1.47
Reliability of the knee examination in osteoarthritis: effect of standardization. Arthritis Rheum (2004) 1.46
A critique and impact analysis of decision modeling assumptions. Med Decis Making (2007) 1.44
Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006. J Subst Abuse Treat (2010) 1.44
When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions. CMAJ (2005) 1.42
Cost-effectiveness: cholinesterase inhibitors and memantine in vascular dementia. Can J Neurol Sci (2009) 1.41
De-escalation of therapy for pediatric medulloblastoma: trade-offs between quality of life and survival. Pediatr Blood Cancer (2014) 1.39
Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study. Thorax (2013) 1.39
Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment. CMAJ (2012) 1.37
Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study. Arthritis Rheum (2009) 1.35
The temporal relationship between per capita alcohol consumption and harm: a systematic review of time lag specifications in aggregate time series analyses. Drug Alcohol Depend (2011) 1.34
Health state utilities in latent and active tuberculosis. Value Health (2008) 1.34
Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis. Arthritis Rheum (2008) 1.33
The cost effectiveness of human papillomavirus vaccines: a systematic review. Drugs (2012) 1.30
Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values. Value Health (2012) 1.30
Biologic drugs for rheumatoid arthritis in the Medicare program: a cost-effectiveness analysis. Arthritis Rheum (2008) 1.28
Predictors of back pain in a general population cohort. Spine (Phila Pa 1976) (2004) 1.28
A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Med Care (2004) 1.27
Descriptive epidemiology of osteoarthritis in British Columbia, Canada. J Rheumatol (2006) 1.27
HIV-positive injection drug users who leave the hospital against medical advice: the mitigating role of methadone and social support. J Acquir Immune Defic Syndr (2004) 1.27
Incorporation of uncertainty in health economic modelling studies. Pharmacoeconomics (2005) 1.27
Should patients have a greater role in valuing health states? Appl Health Econ Health Policy (2005) 1.27
Validity of the work productivity and activity impairment questionnaire--general health version in patients with rheumatoid arthritis. Arthritis Res Ther (2010) 1.26
Proportional hazards frailty models for recurrent methadone maintenance treatment. Am J Epidemiol (2009) 1.26
Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy. CMAJ (2006) 1.24
Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4. Med Decis Making (2012) 1.22
The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review. J Rheumatol (2008) 1.20
Posterior reversible encephalopathy syndrome--an underrecognized manifestation of systemic lupus erythematosus. J Rheumatol (2006) 1.19
The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work. Med Care (2006) 1.17
Return of incidental findings in genomic medicine: measuring what patients value--development of an instrument to measure preferences for information from next-generation testing (IMPRINT). Genet Med (2013) 1.16
Estimating multiparameter partial expected value of perfect information from a probabilistic sensitivity analysis sample: a nonparametric regression approach. Med Decis Making (2013) 1.16
Dual energy CT in gout: a prospective validation study. Ann Rheum Dis (2012) 1.15
Approval process and access to prescription drugs in Canada. Arthritis Rheum (2006) 1.15
Modelling the cost-effectiveness of alcohol screening and brief interventions in primary care in England. Alcohol Alcohol (2012) 1.15
Physical activity as a mediator of the impact of chronic conditions on quality of life in older adults. Health Qual Life Outcomes (2007) 1.13
Identification of modifiable work-related factors that influence the risk of work disability in rheumatoid arthritis. Arthritis Rheum (2004) 1.11
Risk of cardiovascular disease in patients with osteoarthritis: a prospective longitudinal study. Arthritis Care Res (Hoboken) (2013) 1.10
Chemotherapy versus supportive care alone in pediatric palliative care for cancer: comparing the preferences of parents and health care professionals. CMAJ (2011) 1.10
Infliximab treatment of rheumatoid arthritis and Crohn's disease. Ann Pharmacother (2003) 1.10
Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. Rheumatology (Oxford) (2012) 1.10
Trends in physician-diagnosed osteoarthritis incidence in an administrative database in British Columbia, Canada, 1996-1997 through 2003-2004. Arthritis Rheum (2008) 1.10
Health related quality of life trajectories of patients in opioid substitution treatment. Drug Alcohol Depend (2011) 1.09
Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? Qual Life Res (2005) 1.08
Now that we know what's BeSt, what is good value for the money? Arthritis Rheum (2009) 1.07
Quality of nonpharmacological care in the community for people with knee and hip osteoarthritis. J Rheumatol (2011) 1.06
Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J Rheumatol (2008) 1.05
Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--4. Value Health (2012) 1.05
Trends in asthma-related direct medical costs from 2002 to 2007 in British Columbia, Canada: a population based-cohort study. PLoS One (2012) 1.05
Arthritis-related work transitions: a prospective analysis of reported productivity losses, work changes, and leaving the labor force. Arthritis Rheum (2008) 1.05
The independent contribution of executive functions to health related quality of life in older women. BMC Geriatr (2010) 1.04
Risk of breast cancer after onset of type 2 diabetes: evidence of detection bias in postmenopausal women. Diabetes Care (2011) 1.03